USANA HEALTH SCIENCES INC

For the period ended Dec 30, 2023. Filed Feb 27, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Comprehensive Income

	Fiscal Year
	2023	2022	2021
Net sales	$921,010	$998,601	$1,186,464
Cost of sales	176,693	193,890	217,898
Gross profit	744,317	804,711	968,566
Operating expenses:
Associate incentives	394,257	434,793	519,267
Selling, general and administrative	256,989	262,304	279,107
Total operating expenses	651,246	697,097	798,374
Earnings from operations	93,071	107,614	170,192
Other income (expense):
Interest income	9,637	3,789	2,515
Interest expense	(262)	(192)	(57)
Other, net	7	(2,590)	(2,008)
Other income (expense), net	9,382	1,007	450
Earnings before income taxes	102,453	108,621	170,642
Income taxes	38,665	39,271	54,137
Net earnings	$63,788	$69,350	$116,505
Earnings per common share
Basic	$3.31	$3.60	$5.78
Diluted	$3.30	$3.59	$5.73
Weighted average common shares outstanding
Basic	19,250	19,254	20,146
Diluted	19,345	19,310	20,343
Comprehensive income:
Net earnings	$63,788	$69,350	$116,505
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(1,298)	(15,126)	2,203
Tax benefit (expense) related to foreign currency translation adjustment	390	1,881	1,880
Other comprehensive income (loss), net of tax	(908)	(13,245)	4,083
Comprehensive income	$62,880	$56,105	$120,588

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.